Analytical Chemistry,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 12, 2025
The
ultrasensitive
detection
of
microRNAs
(miRNAs)
in
extracellular
vesicles
(EVs)
can
accurately
reflect
the
progress
and
metastasis
miRNA-mediated
intercellular
communication,
providing
an
unprecedented
opportunity
for
liquid
biopsy.
However,
due
to
low
abundance
high
heterogeneity
miRNAs
EVs,
quantification
establishment
a
distribution
model
miRNA
within
native
EVs
remain
challenging.
Here,
we
have
developed
DNA
tetrahedron-based
single-molecule
fluorescence
imaging
strategy
overcome
this
challenge.
internalization
efficiency
probe
was
as
70%
without
disrupting
structure
combined
with
imaging,
achieved
situ
analysis
single-copy
individual
amplification
first
time.
A
new
has
been
revealed
by
statistical
copy
number
across
multiple
cell
lines,
characterized
occupancy
heterogeneous
distribution.
More
importantly,
found
that
drug
resistance
cancer
cells
promote
increase
resistance-related
corresponding
secreted,
insights
into
EV
sorting
mechanisms.
We
anticipate
technology
will
rapidly
advance
communication
based
on
EVs.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Авг. 12, 2024
Cancer
remains
a
significant
risk
to
human
health.
Nanomedicine
is
new
multidisciplinary
field
that
garnering
lot
of
interest
and
investigation.
shows
great
potential
for
cancer
diagnosis
treatment.
Specifically
engineered
nanoparticles
can
be
employed
as
contrast
agents
in
diagnostics
enable
high
sensitivity
high-resolution
tumor
detection
by
imaging
examinations.
Novel
approaches
labeling
are
also
made
possible
the
use
nanoprobes
nanobiosensors.
The
achievement
targeted
medication
delivery
therapy
accomplished
through
rational
design
manufacture
nanodrug
carriers.
Nanoparticles
have
capability
effectively
transport
medications
or
gene
fragments
tissues
via
passive
active
targeting
processes,
thus
enhancing
treatment
outcomes
while
minimizing
harm
healthy
tissues.
Simultaneously,
context
radiation
sensitization
photothermal
enhance
therapeutic
efficacy
malignant
tumors.
This
review
presents
literature
overview
summary
how
nanotechnology
used
According
oncological
diseases
originating
from
different
systems
body
combining
pathophysiological
features
cancers
at
sites,
we
most
recent
developments
applications.
Finally,
briefly
discuss
prospects
challenges
cancer.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(5), С. 2730 - 2730
Опубликована: Фев. 27, 2024
Extracellular
vesicles
(EVs),
a
diverse
group
of
cell-derived
exocytosed
particles,
are
pivotal
in
mediating
intercellular
communication
due
to
their
ability
selectively
transfer
biomolecules
specific
cell
types.
EVs,
composed
proteins,
nucleic
acids,
and
lipids,
taken
up
by
cells
affect
variety
signaling
cascades.
Research
the
field
has
primarily
focused
on
stem
with
particular
focus
mesenchymal
cells,
for
potential
therapeutic
benefits.
Recently,
tissue-specific
EVs
or
type-specific
extracellular
(CTS-EVs),
have
garnered
attention
unique
biogenesis
molecular
composition
because
they
enable
highly
targeted
cell-specific
communication.
Various
studies
outlined
roles
that
CTS-EVs
play
physiological
function
maintenance
homeostasis,
including
immune
modulation,
tissue
regeneration,
organ
development.
These
properties
also
exploited
disease
propagation,
such
as
cancer,
neurological
disorders,
infectious
diseases,
autoimmune
conditions,
more.
The
insights
gained
from
analyzing
different
biological
not
only
enhance
our
understanding
pathogenesis
but
open
new
avenues
innovative
diagnostic
biomarkers
targets
wide
spectrum
medical
conditions.
This
review
comprehensively
outlines
current
CTS-EV
origins,
within
normal
physiology,
implications
diseased
states.
Molecules,
Год журнала:
2023,
Номер
28(12), С. 4768 - 4768
Опубликована: Июнь 14, 2023
Breast
cancer
(BC)
is
characterized
by
an
extensive
genotypic
and
phenotypic
heterogeneity.
In-depth
investigations
into
the
molecular
bases
of
BC
phenotypes,
carcinogenesis,
progression,
metastasis
are
necessary
for
accurate
diagnoses,
prognoses,
therapy
assessments
in
predictive,
precision,
personalized
oncology.
This
review
discusses
both
classic
as
well
several
novel
omics
fields
that
involved
or
should
be
used
modern
investigations,
which
may
integrated
a
holistic
term,
onco-breastomics.
Rapid
recent
advances
profiling
strategies
analytical
techniques
based
on
high-throughput
sequencing
mass
spectrometry
(MS)
development
have
generated
large-scale
multi-omics
datasets,
mainly
emerging
from
three
”big
omics”,
central
dogma
biology:
genomics,
transcriptomics,
proteomics.
Metabolomics-based
approaches
also
reflect
dynamic
response
cells
to
genetic
modifications.
Interactomics
promotes
view
research
constructing
characterizing
protein–protein
interaction
(PPI)
networks
provide
hypothesis
pathophysiological
processes
progression
subtyping.
The
emergence
new
omics-
epiomics-based
multidimensional
opportunities
gain
insights
heterogeneity
its
underlying
mechanisms.
main
epiomics
(epigenomics,
epitranscriptomics,
epiproteomics)
focused
epigenetic
DNA
changes,
RNAs
modifications,
posttranslational
modifications
(PTMs)
affecting
protein
functions
in-depth
understanding
cell
proliferation,
migration,
invasion.
Novel
fields,
such
epichaperomics
epimetabolomics,
could
investigate
interactome
induced
stressors
PPI
metabolites,
drivers
BC-causing
phenotypes.
Over
last
years,
proteomics-derived
omics,
matrisomics,
exosomics,
secretomics,
kinomics,
phosphoproteomics,
immunomics,
provided
valuable
data
deep
dysregulated
pathways
their
tumor
microenvironment
(TME)
immune
(TIMW).
Most
these
datasets
still
assessed
individually
using
distinct
approches
do
not
generate
desired
expected
global-integrative
knowledge
with
applications
clinical
diagnostics.
However,
hyphenated
approaches,
proteo-genomics,
proteo-transcriptomics,
phosphoproteomics-exosomics
useful
identification
putative
biomarkers
therapeutic
targets.
To
develop
non-invasive
diagnostic
tests
discover
BC,
omics-based
allow
significant
blood/plasma-based
omics.
Salivaomics,
urinomics,
milkomics
appear
integrative
high
potential
early
diagnoses
BC.
Thus,
analysis
circulome
considered
frontier
liquid
biopsy.
Omics-based
modeling,
classification
subtype
characterization.
future
single-cell
analyses.
Biomarker Research,
Год журнала:
2023,
Номер
11(1)
Опубликована: Ноя. 17, 2023
Abstract
While
the
field
of
precision
oncology
is
rapidly
expanding
and
more
targeted
options
are
revolutionizing
cancer
treatment
paradigms,
therapeutic
resistance
particularly
to
immunotherapy
remains
a
pressing
challenge.
This
can
be
largely
attributed
dynamic
tumor-stroma
interactions
that
continuously
alter
microenvironment.
date
most
advancements
have
been
made
through
examining
clinical
utility
tissue-based
biomarkers,
their
invasive
nature
lack
holistic
representation
evolving
disease
in
real-time
manner
could
result
suboptimal
decisions.
Thus,
using
minimally-invasive
approaches
identify
biomarkers
predict
monitor
response
as
well
alert
emergence
recurrences
critical
need.
Currently,
research
efforts
shifting
towards
developing
liquid
biopsy-based
obtained
from
patients
over
course
disease.
Liquid
biopsy
represents
unique
opportunity
intercellular
communication
within
tumor
microenvironment
which
occur
exchange
extracellular
vesicles
(EVs).
EVs
lipid
bilayer
membrane
nanoscale
transfer
plethora
biomolecules
mediate
crosstalk,
shape
microenvironment,
modify
drug
response.
The
capture
innovative
approaches,
such
microfluidics,
magnetic
beads,
aptamers,
allow
analysis
via
high
throughput
multi-omics
techniques
facilitate
use
for
biomarker
discovery.
Artificial
intelligence,
machine
deep
learning
algorithms,
advancing
analyses
uncover
candidate
predictive
signatures
key
translation
into
trials.
With
increasing
recognition
role
mediating
immune
evasion
valuable
source,
these
snapshots
cellular
promising
become
an
important
tool
spur
strategies
block
immunotherapy.
In
this
review,
we
discuss
emerging
describing
current
advances
isolation
function
mediators
We
also
highlight
recent
lung
melanoma
studies
point
application
potential
immuno-oncology.
Biomaterials Research,
Год журнала:
2023,
Номер
27(1)
Опубликована: Фев. 9, 2023
Cancer
is
a
complex
illness
that
presents
significant
challenges
in
its
understanding
and
treatment.
The
classic
definition,
"a
group
of
diseases
characterized
by
the
uncontrolled
growth
spread
abnormal
cells
body,"
fails
to
convey
intricate
interaction
between
many
entities
involved
cancer.
Recent
advancements
field
cancer
research
have
shed
light
on
role
played
individual
tumor
microenvironment
as
whole
development
progression.
This
breakthrough
enables
utilization
components
biological
tools,
opening
new
possibilities.
article
delves
deeply
into
concept
"tumor-derived
systems",
an
umbrella
term
for
tools
sourced
from
aid
combatting
it.
It
includes
cell
membrane-coated
nanoparticles
(for
theranostics),
extracellular
vesicles
diagnosis/therapy),
lysates
vaccine
development),
engineered
cells/organoids
research).
review
seeks
offer
complete
overview
tumor-derived
materials
are
utilized
research,
well
their
current
stages
implementation.
aimed
primarily
at
researchers
working
interface
biology
biomedical
engineering,
it
provides
vital
insights
this
fast-growing
topic.
Molecules,
Год журнала:
2024,
Номер
29(19), С. 4672 - 4672
Опубликована: Окт. 1, 2024
Extracellular
vesicles
(EVs)
are
membrane-enclosed
particles
that
have
attracted
much
attention
for
their
potential
in
disease
diagnosis
and
therapy.
However,
the
clinical
translation
is
limited
by
dosing
consistency
due
to
heterogeneity.
Among
various
characterization
techniques,
nanoparticle
tracking
analysis
(NTA)
offers
distinct
benefits
EV
characterization.
In
this
review,
we
will
discuss
NTA
technique
with
a
focus
on
factors
affecting
results;
then,
review
two
modes
of
techniques
along
suitable
applications
specific
areas
studies.
EVs
typically
characterized
size,
size
distribution,
concentration,
protein
markers,
RNA
cargos.
The
light-scattering
mode
accurate
concentration
information
solution,
which
useful
comparing
isolation
methods,
storage
conditions,
secretion
conditions.
contrast,
fluorescent
allows
differentiating
subgroups
based
markers.
success
fluorescence
heavily
relies
tags
(e.g.,
types
dyes
labeling
methods).
When
labeled
disease-specific
an
effective
tool
detection
biological
fluids,
such
as
saliva,
blood,
serum.
Finally,
limitations
future
directions
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(12), С. 6533 - 6533
Опубликована: Июнь 13, 2024
Extracellular
vesicles
(EVs)
hold
great
promise
for
clinical
application
as
new
diagnostic
and
therapeutic
modalities.
This
paper
describes
major
GMP-based
upstream
downstream
manufacturing
processes
EV
large-scale
production,
also
focusing
on
post-processing
technologies
such
surface
bioengineering
uploading
studies
to
yield
novel
EV-based
diagnostics
advanced
therapy
medicinal
products.
focuses
the
quality,
safety,
efficacy
issues
of
bioengineered
drug
candidates
before
first-in-human
studies.
Because
trials
involving
extracellular
are
global
rise,
this
encompasses
different
registered
clinical-trial
register
platforms,
with
varying
levels
advancement,
highlighting
growing
interest
in
EV-related
programs.
Navigating
regulatory
affairs
EVs
poses
real
challenges,
obtaining
marketing
authorization
medicines
remains
complex
due
lack
specific
guidelines
discusses
state-of-the-art
knowledge
date
products,
further
research
needs
safe
reliable
implementation
tools
settings.
Post-marketing
pharmacovigilance
products
is
presented,
mainly
addressing
topics
risk
assessment
management.
International Journal of Nanomedicine,
Год журнала:
2024,
Номер
Volume 19, С. 2241 - 2264
Опубликована: Март 1, 2024
Abstract:
Recently,
gene
therapy
has
become
a
subject
of
considerable
research
and
been
widely
evaluated
in
various
disease
models.
Though
it
is
considered
as
stand-alone
agent
for
COVID-19
vaccination,
still
suffering
from
the
following
drawbacks
during
its
translation
bench
to
bedside:
high
sensitivity
exogenous
nucleic
acids
enzymatic
degradation;
severe
side
effects
induced
either
by
or
components
formulation;
difficulty
cross
barriers
before
reaching
therapeutic
target.
Therefore,
successful
application
therapy,
safe
reliable
transport
vector
urgently
needed.
Extracellular
vesicles
(EVs)
are
ideal
candidate
delivery
drugs
owing
their
low
immunogenicity,
good
biocompatibility
toxicity.
To
better
understand
properties
EVs
advantages
drug
vehicles,
this
review
covers
origin
methods
generation,
well
common
isolation
purification
research,
with
pros
cons
discussed.
Meanwhile,
engineering
also
highlighted.
In
addition,
paper
presents
progress
EVs-mediated
microRNAs,
small
interfering
RNAs,
messenger
plasmids,
antisense
oligonucleotides.
We
believe
will
provide
theoretical
basis
development
drugs.
Keywords:
extracellular
vesicles,
system,
Cell Communication and Signaling,
Год журнала:
2024,
Номер
22(1)
Опубликована: Янв. 19, 2024
Abstract
Breast
cancer,
a
highly
fatal
disease
due
to
its
tendency
metastasize,
is
the
most
prevalent
form
of
malignant
tumors
among
women
worldwide.
Numerous
studies
indicate
that
breast
cancer
exhibits
unique
predilection
for
metastasis
specific
organs
including
bone,
liver,
lung,
and
brain.
However,
different
types
of,
The
understanding
heterogeneity
metastatic
has
notably
improved
with
recent
advances
in
high-throughput
sequencing
techniques.
Focusing
on
modification
microenvironment
crosstalk
between
tumor
cells
situ
cells,
noteworthy
research
points
include
identification
two
distinct
modes
growth
bone
metastases,
influence
type
II
pneumocyte
lung
paradoxical
role
Kupffer
liver
breakthrough
blood-brain
barrier
(BBB)
breach
brain
metastases.
Overall,
this
review
provides
comprehensive
overview
characteristics
shedding
light
pivotal
roles
immune
resident
development
foci.
Graphical
ACS Sensors,
Год журнала:
2024,
Номер
9(4), С. 2194 - 2202
Опубликована: Апрель 15, 2024
Breast
cancer
is
one
of
the
most
diagnosed
cancers
worldwide.
Precise
diagnosis
and
subtyping
have
important
significance
for
targeted
therapy
prognosis
prediction
breast
cancer.
Herein,
we
design
a
proximity-guaranteed
DNA
machine
accurate
identification
extracellular
vesicles
(EVs),
which
beneficial
to
explore
subtype
features
In
our
design,
two
proximity
probes
are
located
close
on
same
EV
through
specific
recognition
coexisting
surface
biomarkers,
thus
being
ligated
with
help
click
chemistry.
Then,
product
initiates
operation
involving
catalytic
hairpin
assembly
clusters
regularly
interspaced
short
palindromic
repeats
(CRISPR)-Cas12a-mediated
trans-cleavage,
finally
generates
significant
response
that
enables
EVs
expressing
both
biomarkers.
Principle-of-proof
studies
performed
using
derived
from
cell
line
BT474
as
models,
confirming
high
sensitivity
specificity
machine.
When
further
applied
clinical
samples,
shown
be
capable
not
only
distinguishing
patients
special
subtypes
but
also
realizing
tumor
staging
regarding
disease
progression.
Therefore,
work
may
provide
new
insights
into
subtype-based
well
more
potential
therapeutic
targets
in
future.